Moderna Inc at UBS BioPharma Conference Transcript
Everyone, I'm Ellie Merle. Thank you so much for joining us at day 2 of the UBS Biopharma Conference here in sunny Miami. Very happy to have Moderna with us this morning. Joining us from Moderna is James Mock, Chief Financial Officer.
Questions & Answers
And with that, maybe just starting high level, walk us through the recent update with the 2023 guidance and how you think about COVID numbers from here?
Okay. Well, first off, thanks for having us, Ellie. It's a pleasure to be here. And maybe let me just step back and talk about what we wanted to frame of it, why we get some 3 years of the financial framework here.
So we've always operated under the same principles. Those principles were that we could always have the ability to flex spending. We've showed that in the past. We're always concerned with financing risk. We've
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |